How to Protect the Vulnerable Groups in Drug Clinical Trials / 中国医学伦理学
Chinese Medical Ethics
;
(6): 572-575, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-619277
ABSTRACT
Objective:
To find a better way to protect the security and interests of vulnerable groups by exploring the problem of protecting the vulnerable groups in drug clinical trial from the perspectives of ethics committees,organization and researchers.Methods:
According to the relevant literature and the actual situation of the hospital,this paper analyzed the security issues of vulnerable groups comprehensively.Results:
Only the ethics committees,organization and researchers work together,can it protect the security and interests of vulnerable groups to the greatest extents.Conclusion:
Further research on the security of vulnerable groups not only promotes the development of human health,but also plays a decisive role in improving the protection of subjects in drug clinical trial.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Medical Ethics
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS